23 Validation of PD-L1 dynamic expression on extracellular vesicles as a predictor of response to immune-checkpoint inhibitors and survival in non-small cell lung cancer patients

• Alessandro Russo,
• Christian Rolfo,
• Andrés Cardona,
• Aung Naing,
• Rivka Colen,
• Christine Peterson,
• Diego de Miguel Perez,
• Muthukumar Gunasekaran,
• Vincenzo Adamo,
• Oscar Arrieta,
• Feliciano Barrón,
• Luis Lara-Mejía,
• Philip Mack,
• Fred Hirsch

Affiliations

Alessandro Russo

Medical Oncology and Department of Human Pathology, Azienda Ospedaliera Papardo and Università degli Studi di Messina, Messina, Italy

Christian Rolfo

Center for Thoracic Oncology at Tisch Cancer Institute, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, New York, USA

Andrés Cardona

Department of Product Development Biometrics, F. Hoffmann-La Roche Ltd, Basel, Basel-Stadt, Switzerland

Aung Naing

Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA

Rivka Colen

Aff106 grid.240145.60000000122914776University of Texas MD Anderson Cancer Center Houston TX USA

Christine Peterson

Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Diego de Miguel Perez

1University of Maryland, Baltimore, MD, USA

Muthukumar Gunasekaran

1University of Maryland, Baltimore, MD, USA

Vincenzo Adamo

Medical Oncology and Department of Human Pathology, Azienda Ospedaliera Papardo and Università degli Studi di Messina, Messina, Italy

Oscar Arrieta

Thoraxic Oncology Unit, Instituto Nacional de Cancerología, Mexico, Mexico

Feliciano Barrón

2Instituto Nacional de Cancerología (INCAN), Mexico city, Mexico

Luis Lara-Mejía

2Instituto Nacional de Cancerología (INCAN), Mexico city, Mexico

Philip Mack

8Tisch Cancer Institute and Icahn School of Medicine, Mount Sinai, NY, New York, NY, USA

Fred Hirsch

8Tisch Cancer Institute and Icahn School of Medicine, Mount Sinai, NY, New York, NY, USA